Patient Assistance Programs for Tirzepatide: How to Apply

Tirzepatide has produced some of the most impressive weight loss results in clinical trial history. In the SURMOUNT trials, patients lost an average of 20% or more of their body weight over 72 weeks. But at a retail list price of over $1,000/month, many people who need this medication can’t afford it — and never get the chance to see what it could do for them. That’s why understanding Patient Assistance Programs for Tirzepatide matters. These programs exist to bridge the gap between those who need the medication and who can access it.

This guide explains exactly which programs are available, who qualifies, and how to apply — without confusion.

What Are Patient Assistance Programs?

Patient Assistance Programs (PAPs) are offered by pharmaceutical companies to help people who cannot afford their medications. They typically provide medication at a reduced cost or free of charge to qualifying individuals.

For tirzepatide specifically, the programs work a little differently depending on:

• Which brand you’re taking (Mounjaro vs. Zepbound)
• What it’s prescribed for (diabetes vs. weight loss)
• Your insurance status
• Your income level

Understanding these differences is the key to finding the right program.

Program #1: The Zepbound Savings Card (Commercial Insurance Required)

Best for: People with commercial (private) insurance whose plan covers Zepbound

This is the most widely used savings pathway for Zepbound patients. The Zepbound Savings Card is offered by Eli Lilly and can reduce your monthly copay to as little as $25 for a 1- or 3-month supply.

Who Qualifies?

• Must have a valid prescription for Zepbound.
• Must be enrolled in a commercial drug insurance plan that covers Zepbound.
• Must not be enrolled in Medicare, Medicaid, VA, TRICARE, or any government-funded health program.
• Must be a U.S. resident aged 18 or older.

How to Apply:

Step 1: Visit the official Zepbound savings page at zepbound.lilly.com/savings.

Step 2: Click “Get the Savings Card”.

Step 3: Enter your name, date of birth, and insurance information.

Step 4: Receive your digital card immediately — or request a physical card.

Step 5: Present the card at your pharmacy when filling your prescription.

Your pharmacy applies the savings automatically on eligible fills. No income documentation is required. No lengthy approval process.

Important note: This card only works if your insurance plan covers Zepbound. If your plan doesn’t cover it, the card can still lower the cost to around $499/month instead of $1,086 — but not to $25. Your provider may need to submit a prior authorization first.

Program #2: The Mounjaro Savings Card (For Diabetes Patients)

Best for: Commercially insured patients prescribed Mounjaro for type 2 diabetes

Mounjaro is the same active ingredient as Zepbound (tirzepatide), but it is FDA-approved specifically for type 2 diabetes management. If your provider prescribes Mounjaro for diabetes, the Mounjaro Savings Card offers the same structure as the Zepbound version.

Eligible commercially insured patients may pay as little as $25/month.

Key distinction: If you’re taking Mounjaro off-label for weight loss (not for diabetes), patient assistance programs do not cover this use. In that case, Zepbound — which is FDA-approved for weight loss — is the better route.

Program #3: LillyDirect Self-Pay Program (No Insurance Needed)

Best for: Uninsured patients or those whose insurance doesn’t cover Zepbound

This is not a traditional Patient Assistance Program — but it functions similarly by dramatically lowering costs through Lilly’s direct-to-consumer pharmacy channel.

Patient Assistance Programs for Tirzepatide don’t always mean free medication. Sometimes they mean a dramatically reduced price that makes treatment genuinely achievable.

LillyDirect currently offers Zepbound single-dose vials at:

• 2.5 mg → $299/month.
• 5 mg → $399/month.
• 7.5 mg–15 mg → $449/month (refill within 45 days).

No insurance is required. You just need a valid prescription and a credit card.

How to access it:

1. Get a prescription from a licensed provider.
2. Visit LillyDirect.lilly.com.
3. Create an account and enter your prescription details.
4. Choose home delivery or Walmart pharmacy pickup.

Program #4: Lilly Cares Foundation (For Mounjaro — Not Zepbound)

Best for: Low-income, uninsured patients using Mounjaro for type 2 diabetes

Lilly Cares is Eli Lilly’s charitable foundation that provides free medications to qualifying patients. Here’s the crucial detail that many people miss:

Lilly Cares currently covers Mounjaro for diabetes — but NOT Zepbound for weight loss.

This distinction matters. If you’re using tirzepatide specifically for weight management through Zepbound, Lilly Cares cannot currently help you. The program may expand coverage in the future, so it’s worth checking periodically.

Lilly Cares eligibility for Mounjaro generally includes:

• U.S. resident with a valid prescription.
• Uninsured or underinsured.
• Income below a qualifying threshold (typically income-based criteria reviewed per applicant).
• Not covered by government insurance programs.

How to apply for Lilly Cares:

1. Call Lilly Cares directly at 1-800-545-6962.
2. Or visit LillyCares.com.
3. Speak with a representative about Mounjaro eligibility.
4. Submit required documentation (prescription, proof of income, insurance status).

Processing typically takes several weeks. Start the application before you run out of medication.

Program #5: State Medicaid Coverage (Varies by State)

Best for: Medicaid recipients with type 2 diabetes

Some state Medicaid programs cover tirzepatide when it’s prescribed for type 2 diabetes. Coverage for weight loss specifically is less common, but some states are expanding obesity medication coverage.

How to check:

• Contact your state’s Medicaid office directly.
• Ask your provider to check your plan’s drug formulary.
• If Zepbound isn’t covered, ask your provider whether Mounjaro (for diabetes) might apply to your situation.

If your state’s Medicaid doesn’t currently cover it, ask your provider to submit a formulary exception or prior authorization — decisions are sometimes reversed.

What About Medicare?

Medicare generally does not cover Zepbound for weight loss. This is because of the Medicare Prescription Drug, Improvement, and Modernization Act, which historically excluded medications used solely for weight management.

Importantly, Medicare patients cannot use manufacturer savings cards like the Zepbound or Mounjaro cards. Federal law prohibits this to prevent anti-kickback compliance issues.

If you’re on Medicare:

• Ask about the Medicare Part D Extra Help Program (Low-Income Subsidy) for general prescription cost help.
• Use the LillyDirect self-pay vial program ($299–$449/month) as your most affordable option.
• Speak with your provider about whether any of your diagnoses might qualify for coverage under a different pathway.

Applying for Assistance: A Universal Checklist

Regardless of which program you’re applying for, gather these documents in advance:

• Valid prescription from a licensed provider.
• Proof of insurance status (or documentation of being uninsured).
• Recent income documentation (pay stubs, tax returns, or letter of income).
• Photo ID and proof of U.S. residency.
• Contact info for your prescribing physician.

Having these ready speeds up every application process significantly.

How TirzepatideRX Online Helps Navigate the Cost Barrier

Not everyone has the time — or patience — to navigate savings programs alone. That’s one reason physician-supervised telehealth programs have become so popular.

TirzepatideRX Online provides a fully managed, physician-guided tirzepatide weight loss program with transparent pricing built for real people. No surprise bills. No insurance battles. Just clear, honest monthly costs that include everything you need.

Their care team can help guide you toward the right savings pathways while keeping your treatment on track. Pricing options include:

• Monthly Plan – $399/month (weekly injections, ongoing monitoring, cancel anytime).
• 3-Month Plan – $1,125 total (full medication supply, quarterly assessments, priority provider access).
• 6-Month Plan – $2,199 total (maximum savings, bi-monthly check-ins, nutritional guidance, premium support).

For people navigating Patient Assistance Programs for Tirzepatide while also trying to maintain consistent care, this type of structured support can be invaluable. Start your journey here or explore more helpful content on the blog.

Real-World Example: What Happened When Robert Applied for Assistance

Robert, 58, was prescribed Mounjaro for type 2 diabetes. Without insurance, the $1,079/month cost was out of reach.

His telehealth provider walked him through the Lilly Cares application. Three weeks later, Robert received approval for free Mounjaro through the foundation. He’s been on it for seven months, his A1C has improved, and he’s lost 31 pounds.

“I didn’t know Lilly Cares existed until my doctor mentioned it. The application took less than an hour. That one phone call changed everything.”

Summary: Which Program Is Right for You?

Frequently Asked Questions

Is there a patient assistance program for Zepbound specifically for weight loss patients with no insurance?

Currently, no free PAP exists for Zepbound; the most affordable option for uninsured patients is LillyDirect, starting at $299/month.

Does Lilly Cares cover Zepbound?

Currently, Lilly Cares covers Mounjaro for type 2 diabetes but does not cover Zepbound for weight loss — check LillyCares.com for updates.

How long does it take to get approved for the Zepbound Savings Card?

The digital savings card is typically available immediately upon online enrollment with no lengthy approval process required.

Can I use the Mounjaro Savings Card if I’m taking it for weight loss (off-label)?

Patient assistance programs for Mounjaro apply only to its FDA-approved use for type 2 diabetes, not for off-label weight loss.

What if I’m denied by all programs?

The LillyDirect self-pay vial program ($299/month) remains available to all eligible U.S. patients with a valid prescription regardless of insurance status.

Sources

1. Lilly Cares Foundation — Official Patient Assistance Program: https://www.lillycares.com
2. Eli Lilly — Zepbound Savings Card Terms & Eligibility: https://zepbound.lilly.com/savings
3. FDA — Mounjaro (Tirzepatide) Prescribing Information: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215866s000lbl.pdf
4. FDA — Zepbound Prescribing Information: https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/217806s003lbl.pdf
5. Medicaid.gov — Prescription Drug Coverage: https://www.medicaid.gov/medicaid/prescription-drugs/index.html

Dr. Teresa Stannard M.D.- Medical Writer & Weight-Loss Specialist

Dr. Teresa Stannard, M.D., brings over 12 years of clinical and healthcare writing expertise to TirzepatideRX.online, where she specializes in GLP-1 therapies, obesity medicine, diabetes, and weight management. With a physician's eye for accuracy and a writer's instinct for clarity, she transforms complex medical science into trusted, patient-centered content — helping readers cut through the noise and make confident, informed decisions about their health.